Viewing Study NCT02441075



Ignite Creation Date: 2024-05-06 @ 4:05 AM
Last Modification Date: 2024-10-26 @ 11:43 AM
Study NCT ID: NCT02441075
Status: COMPLETED
Last Update Posted: 2016-01-29
First Post: 2015-04-30

Brief Title: 70 Ethanol for Decontamination of CVL Exposed to Calcineurine Inhibitors Version 10 192014
Sponsor: Nationwide Childrens Hospital
Organization: Nationwide Childrens Hospital

Study Overview

Official Title: 70 Ethanol for Decontamination of CVL Exposed to Calcineurine Inhibitors Version 10 192014
Status: COMPLETED
Status Verified Date: 2016-01
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: 70 EtOH
Brief Summary: This is for a study for patients that will be undergoing hematopoietic stem cell transplant HSCT For HSCT patients will need a double lumen central venous line CVL One of the most common complications after an HSCT is Graft Versus Host Disease GVHDTacrolimus or Cyclosporine along with methotrexate are used together in order to prevent GVHD Normally these medications are given via the white lumen and blood is drawn via the unexposed red lumen to check the blood level of these medications If these drugs are accidentally given via the wrong lumen line it could cause blood levels to be falsely high This error could lead to the patient having to have peripheral blood draws that cause pain The investigators are proposing adding an ethanol lock to your lumens lines to see if this would help clean the lines therefore preventing errors in blood tests and blood draws An ethanol lock is a 70 alcohol which is injected into the CVL lumen and stays within the CVL as the CVL is capped
Detailed Description: As cyclosporine and tacrolimus are both oil based medications and ethanol 70 alcohol can dissolve oil the investigators hypothesize that an alcohol lock instilled into the lumen of the CVL will be able to dissolve and leach out the oil based CNI adhering to the inside lumen of the CVL catheter thus decontaminating it The safety of using ethanol via CVL is already proven over the last many years A study performed with neonates resulted in no adverse effects when using ethanol locks proving that their use is safe for the pediatric population Ethanol has been used as locks for disinfecting CVLs infected with a broad range of microorganisms in pediatrics It has also been useful in treating catheter occlusions caused by Lipid formation By placing a 70 ethanol lock for two hours in the contaminated lumen it has shown to degrade the biofilm and fat formation allowing for further use of the CVL used 70 ethanol locks and did not find any reductions in mechanical integrity of polyetherurethane or silicone catheters exposed for as long as 10 weeks Also no structural integrity complications have been found in the literature along with no evidence of systemic toxicity with the use of ethanol locks A retrospective study on PICU patients who had received ethanol locks for 12-24 hours per lumen and a repeat lock when venous access was not limited flushed 02-1mls of ethanol through the catheter at the end of the dwell instead of withdrawing the lock Sixteen patients who received five daily ethanol lock treatments in succession had liver enzymes measured and only two patients had mildly elevated transaminases but these levels were not significant from their baseline levels There were also no reports from the nurses of any patient complaints or side effects The study stated that when larger volumes in which they classified as 23mls of ethanol are flushed through the central line patients have reported flushing light-headedness headache nausea and dyspnea Only 2mls of ethanol will be administered in this study and the ethanol lock will be withdrawn prior to drawing the levels Therefore no side effects are expected

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None